Explore drug properties, targets, and indications with answers grounded in DrugCentral.
Powered by DrugCentral + retrieval-augmented AIAsk in your own words. Each question is answered independently.
Select a question to fill the editor, then ask it or make it your own.
Your answer will appear here. Open linked drug cards in a new tab to explore the source details.
Ask DrugCentral helps you explore drug properties, biological targets, and indications using natural language. Sample questions offer starting points, and linked drug cards let you check the underlying records.
Each request is independent; previous questions are not sent as conversation history. You can edit a sample before submitting, retry a failed request, or switch back to normal search. Drug links open in a new tab so your question and answer stay available.
Answers may contain mistakes or omit information. Verify details against DrugCentral records and original sources.
AI can make mistakes. Verify answers against the original sources before relying on them.
| Stem definition | Drug id | CAS RN |
|---|---|---|
| antibacterials, nalidixic acid derivatives | 5532 | 93106-60-6 |
None
None
| Property | Description | Value | Unit | Confidence | Similarity |
|---|---|---|---|---|---|
| kinase-safety-class | ACVR2B,EIF2AK3,GRK2,PDK1,PDK2,PDK4 | 6 | |||
| kinase-selectivity-class | ACVR2B,AXL,CDK9,DYRK1B,EIF2AK3,GRK2,MAPK7,PDK4,PIK3CB,PRKDC,STK33,TEK,TGFBR1,TTK | 14 | |||
| mdck-mdr1-bcrp-efflux | MDCK-MDR1-BCRP efflux ratio | 1.050 | Moderate | 0.77 | |
| pfas-class | PFAS structural alert (1 = True, 0 = False) | 0 | |||
| rat-kpuu-brain | Rat brain Kpuu | 0.129 | % | Moderate | 0.77 |
| Date | Agency | Company | Orphan |
|---|---|---|---|
| None | FDA |
None
None
None
None
| Source | Code | Description |
|---|---|---|
| MeSH PA | D000890 | Anti-Infective Agents |
| MeSH PA | D000900 | Anti-Bacterial Agents |
| CHEBI has role | CHEBI:33281 | antimicrobial agent |
| CHEBI has role | CHEBI:33282 | antibacterial agent |
| CHEBI has role | CHEBI:35610 | antineoplastic agent |
None
| Species | Use | Relation |
|---|---|---|
| Cats | Management of diseases associated with bacteria | Indication |
| Cattle | Bovine respiratory disease (BRD) associated with Mannheimia haemolytica | Indication |
| Cattle | Bovine respiratory disease (BRD) associated with Pasteurella multocida | Indication |
| Cattle | Bovine respiratory disease (BRD) associated with Histophilus somni | Indication |
| Cattle | Bovine respiratory disease (BRD) associated with Mycoplasma bovis | Indication |
| Dogs | Otitis externa complicated by bacterial and fungal organisms | Indication |
| Dogs | Diseases associated with bacteria | Indication |
| Swine | Swine respiratory disease (SRD) associated with Actinobacillus pleuropneumoniae | Indication |
| Swine | Swine respiratory disease (SRD) associated with Pasteurella multocida | Indication |
| Swine | Swine respiratory disease (SRD) associated with Haemophilus parasuis | Indication |
| Swine | Swine respiratory disease (SRD) associated with Streptococcus suis | Indication |
| Swine | Swine respiratory disease (SRD) associated with Bordetella bronchiseptica | Indication |
| Swine | Swine respiratory disease (SRD) associated with Mycoplasma hyopneumoniae | Indication |
| Swine | Colibacillosis associated with Escherichia coli | Indication |
| Product | Applicant | Ingredients |
|---|---|---|
| Baytril Antibacterial Tablets, Baytril Taste Tabs Antibacterial Tablets | Elanco US Inc. | 1 |
| Baytril Antibacterial Injectable Solution | Elanco US Inc. | 1 |
| Baytril 100 Injectable Solution | Elanco US Inc. | 1 |
| Baytril Otic | Elanco US Inc. | 2 |
| Baytril 100-CA1 | Elanco US Inc. | 1 |
| Enroflox 100 | Norbrook Laboratories, Ltd. | 1 |
| Enroflox Injection for Dogs 2.27% | Norbrook Laboratories, Ltd. | 1 |
| Zobuxa | Elanco US Inc. | 1 |
| Enrofloxacin Antibacterial Injectable Solution | Dechra Veterinary Products LLC | 1 |
| Enrofloxacin Flavored Tablets | Dechra Veterinary Products LLC | 1 |
| EnroMed 100 | Bimeda Animal Health Limited | 1 |
| Baytril Soft Chewable Tablets | Elanco US Inc. | 1 |
| ENROFLOXACIN 100 | Sparhawk Laboratories Inc. | 1 |
| Enrofloxacin Flavored Tablets | Felix Pharmaceuticals Pvt. Ltd. | 1 |
| Tenotryl | Virbac AH Inc. | 1 |
| Enrofloxacin | Accord Healthcare Inc. | 1 |
| Enrofloxacin | Felix Pharmaceuticals Pvt. Ltd. | 1 |
| Enroflox Chewable Tablets | Norbrook Laboratories, Ltd. | 1 |
None
None
None
None
| ID | Source |
|---|---|
| CHEBI:35720 | CHEBI |
| CHEMBL15511 | ChEMBL_ID |
| 13668 | IUPHAR_LIGAND_ID |
| DB11404 | DRUGBANK_ID |
| 702749000 | SNOMEDCT_US |
| 96080008 | SNOMEDCT_US |
| C0059374 | UMLSCUI |
| D000077422 | MESH_DESCRIPTOR_UI |
| 5963 | INN_ID |
| D02473 | KEGG_DRUG |
| 71188 | PUBCHEM_CID |
| 017756 | NDDF |
| 3DX3XEK1BN | UNII |
| 204329 | RXNORM |
None